We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Multiplex Molecular Tests Detect Seven Intestinal Parasites

By LabMedica International staff writers
Posted on 28 Mar 2011
Print article
Image: Giardia Lamblia trophozoite (photo courtesy of Raymond Jacobson).
Image: Giardia Lamblia trophozoite (photo courtesy of Raymond Jacobson).
Polymerase chain reaction (PCR) assays for intestinal parasites can be used on fecal DNA samples for enhanced detection of pathogenic organisms.

A multiplex PCR-based assay for the ova and parasite stool examination is now available and the molecular technology is comparable with microscopy and copro-antigen detection systems.

Scientists at the University of Virginia (Charlottesville, VA, USA), adapted several existing real time PCR assays into a high throughput protocol for the major intestinal parasites. Fecal DNA specimens were obtained from 192 preschool-age or younger children from Bangladesh and 190 DNA specimens were obtained from the Leiden University Medical Center (Leiden, Netherlands). Positive control materials were included in this study. The assay involves two multiplex PCR reactions, one with specific primers for the protozoa and one with specific primers for the helminths, after which PCR products are hybridized to beads linked to internal oligonucleotide probes and detected on a Luminex platform (Luminex Corporation, Austin, TX, USA).

The Luminex protozoa assay showed a low limit of detection of 1,000 Giardia lamblia cysts, 100 Cryptosporidium parvum oocysts, and 10 Entamoeba histolytica trophozoites in 200 mg of a stool specimen. The Luminex helminth assay could detect Ancylostoma duodenale, Ascaris lumbricoides, Necator americanus, and Strongyloides stericoralis in very low concentrations. When compared with the parent multiplex real-time PCR assays, this multiplex PCR-bead assay afforded between 83% and 100% sensitivity and specificity on 319 clinical specimens.

The authors concluded that the multiplex PCR-bead protocol provides an alternative high throughput molecular diagnostic platform for specific and sensitive detection of several major intestinal parasites and is a potential alternative to microscopy for equipped laboratories. The study was published in February 2011, in the American Journal of Tropical Medicine and Hygiene.

Related Links:
University of Virginia
Leiden University Medical Center
Luminex Corporation


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Chemistry Analyzer
MS100
New
Centrifuge
Centrifuge 5430/ 5430 R

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.